Dr. Herbert Markley, MD
Neurology (Neurology Physician)
85 Prescott St Ste 101
Worcester, MA 01605
Who else practices at this address →
Worcester County includes primary care (3% of residents) and mental health (11% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Maryland School of Medicine (1968)
- Years since graduation
- 58
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 156
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1968Medical school: University of Maryland School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
MA license 51010
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 156
- Services billed
- 3,829
- Patients’ average age
- 65
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 2,477 | 21 |
| Established patient office or other outpatient visit, 30-39 minutes | 396 | 144 |
| Established patient office or other outpatient visit, 20-29 minutes | 126 | 46 |
| Injection of drug or substance under skin or into muscle | 96 | 24 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 89 | 21 |
| Destruction of first division of face nerve branch | 72 | 21 |
| Injection of trigger points, 3 or more muscles | 28 | 13 |
| New patient office or other outpatient visit, 60-74 minutes | 19 | 19 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Duloxetine Hcl Other prescribers in Worcester, MA | 180 |
| Gabapentin Other prescribers in Worcester, MA | 164 |
| Nurtec Odt (rimegepant sulfate) Other prescribers in Worcester, MA | 158 |
| Ondansetron Hcl Other prescribers in Worcester, MA | 147 |
| Emgality Pen (galcanezumab-gnlm) Other prescribers in Worcester, MA | 139 |
| Pregabalin Other prescribers in Worcester, MA | 132 |
| Qulipta (atogepant) Other prescribers in Worcester, MA | 132 |
| Ubrelvy (ubrogepant) Other prescribers in Worcester, MA | 123 |
| Ajovy Autoinjector (fremanezumab-vfrm) | 121 |
| Rizatriptan (rizatriptan benzoate) Other prescribers in Worcester, MA | 117 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 148 payments worth $7,277 in total to this clinician.
| Axsome Therapeutics, Inc. | $5,041 |
|---|---|
| AbbVie Inc. | $1,306 |
| Pfizer Inc. | $586 |
| Lundbeck LLC | $217 |
| Teva Pharmaceuticals USA, Inc. | $86.98 |
| Lilly USA, LLC | $24.49 |
| Tonix Medicines, Inc. | $14.50 |
| Honoraria | $4,350 |
|---|---|
| Food and Beverage | $2,544 |
| Travel and Lodging | $383 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. Nov 26, 2025 | Honoraria Symbravo · Neurology | $4,350 |
| Axsome Therapeutics, Inc. Nov 7, 2025 | Travel and Lodging Symbravo · Neurology · travel to Scottsdale, AZ · in-kind | $383 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $8,976 in research payments for these studies, mostly to the institutions running them.
- An interventional efficacy and safety phase 3 randomized doubleblind placebocontrolled study with an openlabel extension to investigate rimegepant in migraine prevention in adolescents 12 to less than 18 years of age …
Pfizer Inc. - A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults
Ipsen Innovation · Active, not recruiting · NCT06047444 - A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults
Ipsen Innovation · Active, not recruiting · NCT06047457
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.